Beta
246451

A Review Article on The Investigation of Therapeutic Potential of Sildenafil in Experimentally-Induced Hind Limb Ischemia of Diabetic Model

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Pharmacology and toxicology

Abstract

Sildenafil citrate is a highly selective inhibitor of cyclic guanine monophosphate-specific phosphodiesterase type-5 (PDE-5), leads to smooth muscle relaxation, increases vascular perfusion and tissue blood flow. Clinical and experimental studies previously reported a protective effect of sildenafil in ischemic reperfusion settings in various models. Antioxidants have been reported to reduce ischemia reperfusion injury like vitamin E. Selenium (Se) is one of the most important antioxidants. Antioxidant enzymes such as thioredoxin reductase (TrxR) and glutathione peroxidase along with selenoprotein-P, are responsible for the transport and storage of Se. Nano-elemental Se (SeNPs) are more biocompatible with exhibiting a dramatic decrease in toxicity. Sildenafil and Nano selenium mediated therapeutic angiogenesis in diabetic hind limb ischemia. They improve blood supply, antioxidants delivery for cells and decrease necrosis in peripheral arterial disease (PAD). The induction of therapeutic angiogenesis by sildenafil and SeNPs achieved in this study along with resumed antioxidant defense gives hope of an alternative treatment

DOI

10.21608/rpbs.2022.132107.1134

Keywords

Sildenafil citrate, Nano-Selenium, hind limb ischemia

Authors

First Name

Karim

Last Name

Tawfik

MiddleName

-

Affiliation

Pharmacology & Toxicology Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

Email

karim.twfic.ptd@pharm.suez.edu.eg

City

Suez

Orcid

-

First Name

Reem

Last Name

Hazem

MiddleName

M.

Affiliation

Pharmacology & Toxicology Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

Email

reem_ahmed@pharm.suez.edu.eg

City

Ismailia

Orcid

-

First Name

Pierre

Last Name

Hanna

MiddleName

A.

Affiliation

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

Email

pierre_hanna@pharm.suez.edu.eg

City

Ismailia

Orcid

-

First Name

Mona

Last Name

El-Azab

MiddleName

Farag

Affiliation

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt

Email

mona_elazab@pharm.suez.edu.eg

City

Ismailia

Orcid

0000-0003-4982-445X

First Name

Yasser

Last Name

Moustafa

MiddleName

-

Affiliation

Pharmacology and Toxicology Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

Email

yasser_mostafa@pharm.suez.edu.eg

City

Ismailia

Orcid

-

Volume

6

Article Issue

3

Related Issue

33244

Issue Date

2022-04-01

Receive Date

2022-04-07

Publish Date

2022-04-01

Page Start

86

Page End

112

Print ISSN

2536-9857

Online ISSN

2535-2091

Link

https://rpbs.journals.ekb.eg/article_246451.html

Detail API

https://rpbs.journals.ekb.eg/service?article_code=246451

Order

7

Type

Original Article

Type Code

532

Publication Type

Journal

Publication Title

Records of Pharmaceutical and Biomedical Sciences

Publication Link

https://rpbs.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023